Last update 01 Nov 2024

TG103

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
HyGlutide, Long-acting glucagon-like peptide-1, Recombinant-GLP1-fusion-protein
+ [10]
Target
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Inactive Indication-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
CN
02 Feb 2024
ObesityPhase 3
CN
01 Sep 2023
Diabetes MellitusPhase 3
CN
-
Alzheimer DiseaseIND Approval
CN
31 Aug 2022
Nonalcoholic SteatohepatitisIND Approval
CN
30 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
147
TG103 15.0 mg
(wxlxhrcjsf) = A total of 466 AEs occurred in 45 of the 48 participants, with 35 (97.2%) in the TG103 group and 10 (83.3%) in the pooled placebo group. Most AEs were grade 1 or 2 in severity amgkjktpxn (qwmmyecxtm )
Positive
29 May 2024
TG103 22.5 mg
Phase 1
147
eshfatzfuh(fvesmcjokq) = hgzsjmwdfa ksktwstmlv (htskpdyhfm )
Positive
29 May 2024
eshfatzfuh(fvesmcjokq) = ufdllotkue ksktwstmlv (htskpdyhfm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free